Michel Galinier
Paul Sabatier University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michel Galinier.
PLOS ONE | 2011
Fatima Smih; Franck Desmoulin; Matthieu Berry; Annie Turkieh; Romain Harmancey; Jason Iacovoni; Charlotte Trouillet; Clément Delmas; Atul Pathak; Olivier Lairez; François Koukoui; Pierre Massabuau; Jean Ferrières; Michel Galinier; Philippe Rouet
Background The preclinical stage of systolic heart failure (HF), known as asymptomatic left ventricular dysfunction (ALVD), is diagnosed only by echocardiography, frequent in the general population and leads to a high risk of developing severe HF. Large scale screening for ALVD is a difficult task and represents a major unmet clinical challenge that requires the determination of ALVD biomarkers. Methodology/Principal Findings 294 individuals were screened by echocardiography. We identified 9 ALVD cases out of 128 subjects with cardiovascular risk factors. White blood cell gene expression profiling was performed using pangenomic microarrays. Data were analyzed using principal component analysis (PCA) and Significant Analysis of Microarrays (SAM). To build an ALVD classifier model, we used the nearest centroid classification method (NCCM) with the ClaNC software package. Classification performance was determined using the leave-one-out cross-validation method. Blood transcriptome analysis provided a specific molecular signature for ALVD which defined a model based on 7 genes capable of discriminating ALVD cases. Analysis of an ALVD patients validation group demonstrated that these genes are accurate diagnostic predictors for ALVD with 87% accuracy and 100% precision. Furthermore, Receiver Operating Characteristic curves of expression levels confirmed that 6 out of 7 genes discriminate for left ventricular dysfunction classification. Conclusions/Significance These targets could serve to enhance the ability to efficiently detect ALVD by general care practitioners to facilitate preemptive initiation of medical treatment preventing the development of HF.
Clinical Medicine Insights: Cardiology | 2009
Jérôme Roncalli; L. Perez; Atul Pathak; Laure Spinazze; Sandrine Mazon; Olivier Lairez; Daniel Curnier; Joelle Fourcade; Meyer Elbaz; Didier Carrié; Jacques Puel; Jean-Marie Fauvel; Michel Galinier
Background Interest in the role of patient education sessions for optimizing the management of heart failure (HF) is increasing. We determined whether improvements in young and elderly patients knowledge of HF and self-care behavior could be analyzed by administering a knowledge test before and after an educational session. Methods Stable heart failure patients (n = 115) were enrolled in a prospective cohort study from our Heart Failure educational centre in a university hospital. Patient knowledge of six major HF-related topics was assessed via a questionnaire distributed once before an educational session and twice afterward. Each answer was assigned a numerical value and the final score for each topic could range from 0 to 20. Scores ≥ 15/20 were considered representative of a good level of knowledge. Results The level of knowledge was low (9.7/20) before the educational session but was significantly higher (16.3/20) during the 1st quarter after the session, and this benefit was maintained for up to 12 months (16.6/20). Knowledge levels increased in both younger and elderly patients, and the number of patients who had a good level of knowledge also increased after the educational session. Conclusion This study confirms that an HF knowledge test is feasible and that educational sessions improve the knowledge and self-management of both younger and elderly patients.
Journal of Molecular and Cellular Cardiology | 2007
Jérôme Roncalli; F. Smih; Franck Desmoulin; N. Dumonteil; R. Harmancey; S. Hennig; L. Perez; Atul Pathak; Michel Galinier; P. Massabuau; Myriam Malet-Martino; J.M. Senard; Philippe Rouet
European Research in Telemedicine / La Recherche Européenne en Télémédecine | 2014
H. Bendelac; Atul Pathak; L. Molinier; J.-B. Ruidavets; A. Mayère; M. Berry; C. Delmas; Jérôme Roncalli; Michel Galinier
MT Cardio | 2006
Fabien Despas; Olivier Xhaet; Jean-Michel Senard; Patrick Verwaerde; Géraldine Jourdan; Daniel Curnier; Michel Galinier; Atul Pathak
/data/revues/00029149/unassign/S0002914914000587/ | 2014
Olivier Hanon; Jean-Sébastien Vidal; Pascal de Groote; Michel Galinier; Richard Isnard; Damien Logeart; Michel Komajda
Archive | 2013
Philippe Rouet; Fatima Smih-rouet; Franck Desmoulin; Michel Galinier
Archive | 2010
Alain Cohen-Solal; Erwan Donal; Jean F. Aupetit; Marie Claude Aumont; Michel Galinier; Jean C. Patrick Jourdain; G. Jondeau; François Funck; Pascal Gueffet
Archive | 2010
Philippe Maury; Joelle Fourcade; Alexandre Duparc; Anne Rollin; Nicolas Detis; Aurélien Hébrard; Marc Delay; Meyer Elbaz; Didier Carrié; Michel Galinier
/data/revues/18786480/00020001/30_2/ | 2010
Benjamin Honton; Nicolas Dumonteil; Caroline Rouvellat; Murielle Roussel; Fabien Despas; Didier Carrié; Michel Galinier; Atul Pathak